Diagnostic features and literature review of acute coronary syndrome induced by fluorouracil

doi:10.3877/cma.j.issn.2095-655X.2019.03.003

Abstract

Abstract:

Objective

To explore the diagnostic features of acute coronary syndrome induced by fluorouracil.

Methods

A case of acute coronary syndrome after fluorouracil chemotherapy who was treated for colon cancer in the oncology department of Zhongshan Hospital Affiliated to Fudan University was retrospectively analyzed, the relevant literatures were reviewed.

Results

A 60-year-old male colon cancer patient combined with coronary heart disease who underwent percutaneous coronary intervention accepted the first cycle adjuvant chemotherapy FOLFOX (fluorouracil, calcium folinate, oxaliplatin) regimen. On the 14th day after chemotherapy, he developed chest tightness, persistent chest pain, inability to lie flat, sitting breathing and shortness of breath. Both serum cardiac troponin (cTnT) level (0.687 μg/L) and N-terminal pro B-type natriuretic (NT-proBNP) level (7 128 ng/L) increased significantly, ECG revealed persistent myocardial ischemia changes and pulmonary CTA showed no definite embolism signs. Excluding other pathological and drug factors, acute coronary syndrome caused by fluorouracil was considered. After the symptomatic supportive treatment, the levels of cTnT and NT-proBNP reduced gradually while the patient no longer complained of chest tightness or chest pain. The surveillance of ECG and TTE during and after TOMOX(oxaliplatin, raltitrexed) regimen had no difference and the level of cTnT decreased to the normal.

Conclusion

Patients receiving fluorouracil should be monitored carefully of drug-induced cardiotoxicity, such as acute coronary syndrome, to ensure the smooth progress of chemotherapy.

Key words: Fluorouracil, Chemotherapy, adjuvant, Acute coronary syndrome, Coronary heart disease, Colon cancer

Chunhui Wang, Jing Li, Wei Wu, Jinyi Lin, Yuchen Xu, Qianzhou Lyu, Leilei Cheng. Diagnostic features and literature review of acute coronary syndrome induced by fluorouracil[J]. Chinese Journal of Diagnostics(Electronic Edition), 2019, 07(03): 151-154.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhzdxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-655X.2019.03.003

https://zhzdxdzzz.cma-cmc.com.cn/EN/Y2019/V07/I03/151

Figures/Tables 1

References 13

[1]	Deboever G, Hiltrop N, Cool M，et al.Alternative treatment options in colorectal cancer patients with 5-fluorouracil-or capecitabine-induced cardiotoxicity[J]．Clin Colorectal Cancer，2013，12(1):8-14.
[2]	Kwakman JJ, Simkens LH, Mol L，et al.Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer：a retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group[J] .Eur J Cancer，2017(76):93-99.
[3]	Polk A, Vistisen K, Vaage-Nilsen M，et al.A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity[J]．BMC Pharmacol Toxicol，2014，15(1):47.
[4]	Alter P, Herzum M, SoufiI M，et al.Cardiotoxicity of 5-fluorouracil[J]．Cardiovasc Hematol Agents Med Chem，2006，4(1):1-5.
[5]	Sorrentino MF, Kim J, Foderaro AE，et al.5-fluorouracil induced cardiotoxicity: review of the literature[J]．Cardiol J，2012，19(5):453-458.
[6]	Polk A, Vaage-Nilsen M, Vistisen K，et al.Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine：a systematic review of incidence，manifestations and predisposing factors[J]．Cancer Treat Rev，2013，39(8):974-984.
[7]	Meydan N, Kundak I, Yavuzsen T, et al.Cardiotoxicity of de Gramont′s regimen：incidence，clinical characteristics and long-term follow-up[J]．Jpn J Clin Oncol，2005，35(5):265-270.
[8]	Saif MW, Shah MM, Shah AR.Fluoropyrimidine-associated cardiotoxicity：revisited[J]．Expert Opin Drug Saf，2009，8(2):191-202.
[9]	Kosmas C, Kallistratos MS, Kopterides P, et al.Cardiotoxicity of fluoropyrimidines in different schedules of administration：a prospective study[J]．J Cancer Res Clin Oncol，2008，134(1):75-82.
[10]	Khan MA, Masood N, Husain N, et al.A retrospective study of cardiotoxicities induced by 5-fluouracil (5-FU) and 5-FU based chemotherapy regimens in Pakistani adult cancer patients at Shaukat Khanum Memorial Cancer Hospital & Research Center[J]．J PakMed Assoc，2012，62(5):430-434.
[11]	林果为，王吉耀，葛均波．实用内科学 [M].15版．北京：人民卫生出版社，2017：975-978.
[12]	Yamada Y, Hamaguchi T, Goto M，et al.Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1，a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine，as compared with protracted venous infusion of 5-fluorouracil[J]．Br J Cancer，2003，89(5):816-820.
[13]	Sara JD, Kaur J, Khodadadi R，et al.5-fluorouracil and cardiotoxicity：a review[J]．Ther Adv Med Oncol，2018(10):1758835918780140.

指标	入院后第1天	入院后第12天	入院后第17天	入院后第31天	入院后第74天	入院后第187天
心肌肌钙蛋白T(μg/L)	0.687	0.238	0.157	0.051	0.030	0.024
氨基末端利钠肽前体(ng/L)	7 128	4 933	2 487	2 278	1 181	1 118
红细胞计数(×10¹²/L)	2.81	1.47	1.36	1.41	3.49	3.63
血红蛋白(g/L)	83	49	52	60	127	121

指标	入院后第1天	入院后第12天	入院后第17天	入院后第31天	入院后第74天	入院后第187天
心肌肌钙蛋白T(μg/L)	0.687	0.238	0.157	0.051	0.030	0.024
氨基末端利钠肽前体(ng/L)	7 128	4 933	2 487	2 278	1 181	1 118
红细胞计数(×10¹²/L)	2.81	1.47	1.36	1.41	3.49	3.63
血红蛋白(g/L)	83	49	52	60	127	121

[1]	Wanwei Zhang, Yunyun Qin, Qizhe Cai, Mingming Lin, Runyu Tian, Shan Jin, Xiuzhang Lyu. Value of myocardial early systolic lengthening in non-ST-segment elevation acute coronary syndrome for predicting severe coronary artery stenosis [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1016-1022.
[2]	Xiuhua Sun, Yuan Ma, Linyan Qian, Jianlei Zheng, Hao Zheng, Lihong Wang, Wenwei Cai. Effects of Danlou tablets on angina pectoris symptom and heart function after percutaneous coronary intervention in acute coronary syndrome patients with phlegm and blood stasis syndrome [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2022, 15(05): 367-371.
[3]	Chunzai Feng, Hong Chen, Hao Sun, Siquan Zhong, Shaowei Ye, Shihai Zhou. Hetao method and purse-string forceps method of insertion of anvil in natural orifice specimen extraction surgery with CRC-Ⅳ type: A comparative study [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(02): 119-123.
[4]	Ran Sun, Ming Chen, Yun Chen. D3 lymphadenectomy in right colon cancer with different medial boundaries: A prospective comparative study [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(01): 59-62.
[5]	Jian Liu, Enlin Zhang, Xiaobo Yang, Miao Wu. Cooperation in the "page-turning" 3D laparoscopic right hemi-colectomy with cranial-to-caudal approach [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2022, 15(05): 303-306.
[6]	Xin Tang, Dechang Diao, Weilin Liao, Jiaxin Lin, Jiahao Wang, Wenjuan Li, Jiaxin Xie, Lin Ao, Hongming Li, Xiaojiang Yi, Xinquan Lu, Xiaochuang Feng. Short-term and long-term outcomes of nerve-sparing sheath outside-sheath separation technique in D3 radical resection for right-sided colon cancer under laparoscope: A retrospective cohort study based on propensity score matching [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(05): 372-380.
[7]	Zhenru Deng, Shuwen Lin, Zejian Lv, Jiabin Zheng, Qianchao Liao, Huolun Feng, Deqing Wu, Junjiang Wang, Yong Li. Comparison of transverse colectomy and extended colectomy in the treatment of transverse colon cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(03): 214-220.
[8]	Yingru Li, Fei Li, Yuru Zhang, Liting Liu. Application of "single point-pressure" injection of carbon nanoparticles in abdominal radical resection of colon cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 414-417.
[9]	Chenglin Piao, Xin Lan, Zhenduo Si, Jian Feng, Fengduo An, Qiang Li, Mingkun Tan, Na Zhao, Jianjun Leng. Efficacy of radical resection combined with pancreaticoduodenectomy for locally advanced right colon cancer: report of five cases [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 666-670.
[10]	Jie Chen, Feng Zhou, Jinbo Liu, Hongyu Wang. Drug therapy pattern and population heterogeneity of patients with coronary heart disease based on cluster analysis [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(10): 1012-1018.
[11]	Qi Cai, Yonghong Yong, Hua He, Tongsheng She, Hui Yu. Evaluation of left ventricular function in patients with coronary heart disease by three-dimensional speckle tracking imaging combined with serum homocysteine [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(05): 425-430.
[12]	Yihua Zheng, Xiaodan Chen, Huiyan Wu, Youchao Zhan. The combined value of IMA, H-FABP, soluble ST2 and GRACE score in the early diagnosis of acute coronary syndrome [J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2023, 11(01): 10-15.
[13]	Fanhui Yan, Mingli Zhao, Ying Li, Fangming Guo, Jingdong Zhan, Yingjie Zhao, Yang Wang, Yanfen Zhang, Xiaomei Zhao. Study on the correlation between the degree of coronary vascular lesion and serum levels of TNF-α and VEGF in patients with acute coronary syndrome [J]. Chinese Journal of Diagnostics(Electronic Edition), 2023, 11(03): 158-164.
[14]	Yicheng Guo, Zhipeng Xie, Wanli Liu, Yang Zhao, Yansheng Che, Min Zhao. Characteristic analysis of precordial referred pain caused by osteoporotic vertebral compression fracture in the 12th thoracic vertebrae misdiagnosed as coronary heart disease [J]. Chinese Journal of Diagnostics(Electronic Edition), 2023, 11(02): 136-139.
[15]	Shaohua Guo, Shijia Geng, Shenda Hong, Guanyu Mu, Yizhi Zhang, Lei Yang, Tong Liu, Kangyin Chen. Use of an artificial intelligence-enabled electrocardiogram for screening people without coronary heart disease [J]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2023, 11(01): 18-23.

Please choose a citation manager

Content to export